Group One Trading’s Takeda Pharmaceutical TAK Stock Holding History

Group One Trading’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-147	Closed	-$2.18K	–	9127
2025 Q2	$2.27K	Sell	147 -100	-40%	-$1.48K	﹤0.01%	7381
2025 Q1	$3.67K	Sell	247 -28	-10%	-$392	﹤0.01%	6773
2024 Q4	$3.64K	Sell	275 -7,607	-97%	-$104K	﹤0.01%	6548
2024 Q3	$112K	Buy	+7,882	New	+$112K	﹤0.01%	4083
2023 Q3	–	Sell	-4,975	Closed	-$77K	–	8288
2023 Q2	$78.2K	Sell	4,975 -10,963	-69%	-$180K	﹤0.01%	4864
2023 Q1	$263K	Buy	+15,938	New	+$254K	﹤0.01%	3413
2022 Q4	–	Sell	-18,386	Closed	-$257K	–	8066
2022 Q3	$238K	Sell	18,386 -35,346	-66%	-$491K	﹤0.01%	3966
2022 Q2	$754K	Buy	53,732 +31,403	+141%	+$448K	﹤0.01%	3020
2022 Q1	$320K	Buy	+22,329	New	+$328K	﹤0.01%	4304
2021 Q1	–	Sell	-39,227	Closed	-$706K	–	8012
2020 Q4	$714K	Buy	+39,227	New	+$688K	﹤0.01%	2949
2019 Q2	–	Sell	-19,202	Closed	-$349K	–	5376
2019 Q1	$391K	Buy	+19,202	New	+$386K	﹤0.01%	2152

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Group One Trading's TAK Position: Q3 2025 in Review

Group One Trading sold out of Takeda Pharmaceutical (TAK) in Q3 2025, closing a stake of 147 shares — an estimated $2.18K sold.

Group One Trading first reported a position in TAK in Q1 2019 and held it in 11 quarters. The position peaked at $754K in Q2 2022. 330 funds tracked by Wall St. Rank hold TAK as of Q3 2025.

Group One Trading reported no remaining Takeda Pharmaceutical position as of Q3 2025 after selling out during the quarter.
Group One Trading sold 147 Takeda Pharmaceutical shares in Q3 2025, an estimated $2.18K.
Group One Trading first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 11 quarters.
Group One Trading's Takeda Pharmaceutical position peaked at $754K in Q2 2022.
330 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.